Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Kendall DM"" wg kryterium: Wszystkie pola


Tytuł :
Understanding inhaled Technosphere Insulin: Results of an early randomized trial in type 1 diabetes mellitus.
Autorzy :
McGill JB; Division of Endocrinology, Metabolism and Lipid Research, Washington University School of Medicine, St Louis, Missouri, USA.
Weiss D; Your Diabetes Endocrine Nutrition Group, Inc, Mentor, Ohio, USA.
Grant M; MannKind Corporation, Westlake Village, California, USA.
Jones MC; MannKind Corporation, Westlake Village, California, USA.
Kendall DM; MannKind Corporation, Westlake Village, California, USA.
Hoogwerf BJ; Endocrinology, Diabetes and Metabolism (Emeritus), Cleveland Clinic, Cleveland, Ohio, USA.
Pokaż więcej
Źródło :
Journal of diabetes [J Diabetes] 2021 Feb; Vol. 13 (2), pp. 164-172. Date of Electronic Publication: 2020 Sep 04.
Typ publikacji :
Journal Article; Randomized Controlled Trial
MeSH Terms :
Blood Glucose/*analysis
Diabetes Mellitus, Type 1/*drug therapy
Glycated Hemoglobin A/*analysis
Hypoglycemic Agents/*therapeutic use
Insulin/*therapeutic use
Administration, Inhalation ; Adult ; Diabetes Mellitus, Type 1/blood ; Female ; Humans ; Hypoglycemic Agents/administration & dosage ; Insulin/administration & dosage ; Male ; Middle Aged ; Treatment Outcome
Czasopismo naukowe
Tytuł :
RESULTS OF A 24-WEEK TRIAL OF TECHNOSPHERE INSULIN VERSUS INSULIN ASPART IN TYPE 2 DIABETES.
Autorzy :
Hoogwerf BJ; Department of Endocrinology, Diabetes, and Metabolism (Emeritus), Cleveland, Ohio.
Pantalone KM; Endocrinology and Metabolism Institute, Cleveland Clinic, Cleveland, Ohio.
Basina M; Division of Endocrinology, Gerontology, and Metabolism, Stanford University School of Medicine, Stanford, California.
Jones MC; MannKind Corporation, Westlake Village, California. Electronic address: .
Grant M; MannKind Corporation, Westlake Village, California.
Kendall DM; MannKind Corporation, Westlake Village, California.
Pokaż więcej
Źródło :
Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists [Endocr Pract] 2021 Jan; Vol. 27 (1), pp. 38-43. Date of Electronic Publication: 2020 Nov 17.
Typ publikacji :
Journal Article; Randomized Controlled Trial
MeSH Terms :
Diabetes Mellitus, Type 2*/drug therapy
Insulin Aspart*
Adolescent ; Adult ; Aged ; Aged, 80 and over ; Blood Glucose ; Glycated Hemoglobin A/analysis ; Humans ; Hypoglycemic Agents ; Insulin ; Insulin Glargine ; Insulin, Long-Acting ; Male ; Middle Aged ; Young Adult
Czasopismo naukowe
Tytuł :
Comprehensive Pulmonary Safety Review of Inhaled Technosphere Insulin in Patients with Diabetes Mellitus.
Autorzy :
McGill JB; Washington University School of Medicine, St Louis, MO, USA.
Peters A; Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
Buse JB; University of North Carolina School of Medicine, Chapel Hill, NC, USA.
Steiner S; MannKind Corporation, Westlake Village, CA, USA.
Tran T; MannKind Corporation, Westlake Village, CA, USA.
Pompilio FM; MannKind Corporation, Westlake Village, CA, USA.; Arcutis Biotherapeutics, Inc, Westlake Village, CA, USA.
Kendall DM; MannKind Corporation, Westlake Village, CA, USA. .
Pokaż więcej
Źródło :
Clinical drug investigation [Clin Drug Investig] 2020 Oct; Vol. 40 (10), pp. 973-983.
Typ publikacji :
Journal Article
MeSH Terms :
Diabetes Mellitus, Type 2/*drug therapy
Hypoglycemic Agents/*administration & dosage
Insulin/*administration & dosage
Lung/*drug effects
Administration, Inhalation ; Adult ; Blood Glucose/metabolism ; Cough/drug therapy ; Female ; Humans ; Hypoglycemic Agents/adverse effects ; Insulin/adverse effects ; Male ; Middle Aged ; Postprandial Period ; Powders/therapeutic use ; Retrospective Studies
Czasopismo naukowe
Tytuł :
Hypoglycaemia is reduced with use of inhaled Technosphere Insulin relative to insulin aspart in type 1 diabetes mellitus.
Autorzy :
Seaquist ER; University of Minnesota, Minneapolis, MN, USA.
Blonde L; Ochsner Medical Center, New Orleans, LA, USA.
McGill JB; Washington University School of Medicine, St Louis, MO, USA.
Heller SR; University of Sheffield, Sheffield, UK.
Kendall DM; MannKind Corporation, Westlake Village, CA, USA.
Bumpass JB; MannKind Corporation, Westlake Village, CA, USA.
Pompilio FM; MannKind Corporation, Westlake Village, CA, USA.
Grant ML; MannKind Corporation, Westlake Village, CA, USA.
Pokaż więcej
Źródło :
Diabetic medicine : a journal of the British Diabetic Association [Diabet Med] 2020 May; Vol. 37 (5), pp. 752-759. Date of Electronic Publication: 2019 Dec 19.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
Czasopismo naukowe
Tytuł :
A multinational observational study assessing insulin use: Understanding the determinants associated with progression of therapy.
Autorzy :
Ray KK; Faculty of Medicine, School of Public Health, Imperial College, London, UK.
Kendall DM; Global Health Outcomes, Eli Lilly and Company, Indianapolis, Indiana.
Zhao Z; Global Health Outcomes, Eli Lilly and Company, Indianapolis, Indiana.
Peng X; Global Health Outcomes, Eli Lilly and Company, Indianapolis, Indiana.
Caballero AE; Harvard Medical School, Boston, Massachusetts.
Polonsky WH; Behavioral Diabetes Institute, San Diego, California.
Nordstrom BL; Real-world Evidence, Evidera, Waltham, Massachusetts.
Fan L; Global Health Outcomes, Eli Lilly and Company, Indianapolis, Indiana.
Curtis BH; Global Health Outcomes, Eli Lilly and Company, Indianapolis, Indiana.
Davies MJ; Diabetes Research Centre, University of Leicester, Leicester, UK.
Pokaż więcej
Źródło :
Diabetes, obesity & metabolism [Diabetes Obes Metab] 2019 May; Vol. 21 (5), pp. 1101-1110. Date of Electronic Publication: 2019 Jan 24.
Typ publikacji :
Journal Article; Multicenter Study; Observational Study; Research Support, Non-U.S. Gov't
MeSH Terms :
Diabetes Mellitus, Type 2/*drug therapy
Diabetes Mellitus, Type 2/*pathology
Insulin/*therapeutic use
Aged ; Diabetes Mellitus, Type 2/complications ; Diabetes Mellitus, Type 2/economics ; Disease Progression ; Female ; Follow-Up Studies ; Health Knowledge, Attitudes, Practice ; Health Services Accessibility/economics ; Health Services Accessibility/statistics & numerical data ; Humans ; Income ; Insulin/economics ; Male ; Middle Aged ; Self Efficacy ; Socioeconomic Factors
Czasopismo naukowe
Tytuł :
Identifying insulin treatment responders with a composite measure: beyond Hba1c < 7% in patients with type 2 diabetes.
Autorzy :
Conget I; a Endocrinology and Diabetes Unit , Hospital Clinic I Universitari , Barcelona , Spain.
Kirkman MS; b Division of Endocrinology , University of North Carolina , Chapel Hill , NC , USA.
Cao D; c Eli Lilly and Company , Indianapolis , IN , USA.
Wong M; c Eli Lilly and Company , Indianapolis , IN , USA.
Reviriego J; d Eli Lilly and Company , Madrid , Spain.
Kendall DM; c Eli Lilly and Company , Indianapolis , IN , USA.
Pokaż więcej
Źródło :
Current medical research and opinion [Curr Med Res Opin] 2018 Feb; Vol. 34 (2), pp. 329-336. Date of Electronic Publication: 2017 Nov 24.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Diabetes Mellitus, Type 2*/diagnosis
Diabetes Mellitus, Type 2*/drug therapy
Insulin Lispro*/administration & dosage
Insulin Lispro*/adverse effects
Glycated Hemoglobin A/*analysis
Aged ; Biomarkers/analysis ; Databases, Factual/statistics & numerical data ; Drug Monitoring/methods ; Endpoint Determination/methods ; Female ; Humans ; Hypoglycemic Agents/administration & dosage ; Hypoglycemic Agents/adverse effects ; Male ; Middle Aged ; Outcome Assessment, Health Care/methods
Czasopismo naukowe
Tytuł :
Liraglutide to Improve corONary haemodynamics during Exercise streSS (LIONESS): a double-blind randomised placebo-controlled crossover trial.
Autorzy :
Myat, Aung (AUTHOR)
Redwood, Simon R. (AUTHOR)
Arri, Satpal (AUTHOR)
Gersh, Bernard J. (AUTHOR)
Bhatt, Deepak L. (AUTHOR)
Marber, Michael S. (AUTHOR)
Pokaż więcej
Źródło :
Diabetology & Metabolic Syndrome. 2/12/2021, Vol. 13 Issue 1, p1-14. 14p.
Czasopismo naukowe
Tytuł :
The Future of Incretin-Based Approaches for Neurodegenerative Diseases in Older Adults: Which to Choose? A Review of their Potential Efficacy and Suitability.
Autorzy :
Girges C; Department of Clinical and Movement Neurosciences, UCL Institute of Neurology, London, UK.; The National Hospital for Neurology and Neurosurgery, Queen Square, London, UK.
Vijiaratnam N; Department of Clinical and Movement Neurosciences, UCL Institute of Neurology, London, UK.; The National Hospital for Neurology and Neurosurgery, Queen Square, London, UK.
Athauda D; Department of Clinical and Movement Neurosciences, UCL Institute of Neurology, London, UK.; The National Hospital for Neurology and Neurosurgery, Queen Square, London, UK.
Auld G; Comprehensive Clinical Trials Unit, UCL, London, UK.
Gandhi S; Department of Clinical and Movement Neurosciences, UCL Institute of Neurology, London, UK.; The National Hospital for Neurology and Neurosurgery, Queen Square, London, UK.
Foltynie T; Department of Clinical and Movement Neurosciences, UCL Institute of Neurology, London, UK. .; The National Hospital for Neurology and Neurosurgery, Queen Square, London, UK. .
Pokaż więcej
Źródło :
Drugs & aging [Drugs Aging] 2021 Mar 19. Date of Electronic Publication: 2021 Mar 19.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Effect of diabetes on caregiver burden in an observational study of individuals with Alzheimer's disease.
Autorzy :
Lebrec J; Lilly Deutschland GmbH, Bad Homburg, Germany.
Ascher-Svanum H; Eli Lilly and Company, Indianapolis, IN, USA.
Chen YF; Eli Lilly and Company, Indianapolis, IN, USA.
Reed C; Eli Lilly and Company Limited, Lilly Research Centre, Windlesham, Surrey, UK. .
Kahle-Wrobleski K; Eli Lilly and Company, Indianapolis, IN, USA.
Hake AM; Eli Lilly and Company, Indianapolis, IN, USA.; Department of Neurology, Indiana University School of Medicine, Indianapolis, IN, USA.
Raskin J; Eli Lilly and Company, Toronto, Canada.
Naderali E; Eli Lilly and Company, Lilly House, Basingstoke, Hampshire, UK.; Faculty of Science, Liverpool Hope University, Liverpool, UK.
Schuster D; Eli Lilly and Company, Indianapolis, IN, USA.
Heine RJ; Eli Lilly and Company, Indianapolis, IN, USA.
Kendall DM; Eli Lilly and Company, Indianapolis, IN, USA.
Pokaż więcej
Źródło :
BMC geriatrics [BMC Geriatr] 2016 May 03; Vol. 16, pp. 93. Date of Electronic Publication: 2016 May 03.
Typ publikacji :
Journal Article; Multicenter Study; Observational Study; Research Support, Non-U.S. Gov't
MeSH Terms :
Cost of Illness*
Alzheimer Disease/*epidemiology
Alzheimer Disease/*psychology
Caregivers/*psychology
Diabetes Mellitus/*epidemiology
Diabetes Mellitus/*psychology
Activities of Daily Living/psychology ; Adaptation, Psychological ; Aged ; Aged, 80 and over ; Alzheimer Disease/diagnosis ; Cross-Sectional Studies ; Diabetes Mellitus/diagnosis ; Female ; France/epidemiology ; Germany/epidemiology ; Health Resources/statistics & numerical data ; Health Resources/trends ; Humans ; Male ; Prospective Studies ; United Kingdom/epidemiology
Czasopismo naukowe
Tytuł :
Latin American Expert Consensus for Comprehensive Management of Type 2 Diabetes from a Metabolic–Cardio–Renal Perspective for the Primary Care Physician.
Autorzy :
Mehta, Roopa (AUTHOR)
Pichel, Daniel (AUTHOR)
Chen-Ku, Chih Hao (AUTHOR)
Raffaele, Pablo (AUTHOR)
Méndez Durán, Antonio (AUTHOR)
Padilla, Francisco (AUTHOR)
Arango Alvarez, Jose Javier (AUTHOR)
Esteban Costa Gil, José (AUTHOR)
Esteban Gómez Mesa, Juan (AUTHOR)
Giorgi, Mariano (AUTHOR)
Lahsen, Rodolfo (AUTHOR)
Sposito, Andrei C. (AUTHOR)
Pokaż więcej
Źródło :
Diabetes Therapy. 2021, Vol. 12 Issue 1, p1-20. 20p.
Czasopismo naukowe
Tytuł :
Erratum to: Early Glycemic Response Predicts Achievement of Subsequent Treatment Targets in the Treatment of Type 2 Diabetes: A Post hoc Analysis.
Autorzy :
Fu H; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, 46285, USA. .
Cao D; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, 46285, USA.
Boye KS; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, 46285, USA.
Curtis B; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, 46285, USA.
Schuster DL; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, 46285, USA.
Kendall DM; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, 46285, USA.
Ascher-Svanum H; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, 46285, USA.
Pokaż więcej
Źródło :
Diabetes therapy : research, treatment and education of diabetes and related disorders [Diabetes Ther] 2015 Dec; Vol. 6 (4), pp. 651.
Typ publikacji :
Journal Article; Published Erratum
Czasopismo naukowe
Tytuł :
Associations Between Glycemic Control, Depressed Mood, Clinical Depression, and Diabetes Distress Before and After Insulin Initiation: An Exploratory, Post Hoc Analysis.
Autorzy :
Ascher-Svanum H; Eli Lilly and Company, Indianapolis, IN, USA. .
Zagar A; Eli Lilly and Company, Indianapolis, IN, USA.
Jiang D; Eli Lilly and Company, Indianapolis, IN, USA.
Schuster D; Eli Lilly and Company, Indianapolis, IN, USA.
Schmitt H; Eli Lilly Benelux, Brussels, Belgium.
Dennehy EB; Eli Lilly and Company, Indianapolis, IN, USA.; Department of Psychological Sciences, Purdue University, West Lafayette, IN, USA.
Kendall DM; Eli Lilly and Company, Indianapolis, IN, USA.
Raskin J; Eli Lilly and Company, Indianapolis, IN, USA.
Heine RJ; Eli Lilly Canada, Toronto, ON, Canada.
Pokaż więcej
Źródło :
Diabetes therapy : research, treatment and education of diabetes and related disorders [Diabetes Ther] 2015 Sep; Vol. 6 (3), pp. 303-16. Date of Electronic Publication: 2015 Jul 10.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Early Glycemic Response Predicts Achievement of Subsequent Treatment Targets in the Treatment of Type 2 Diabetes: A Post hoc Analysis.
Autorzy :
Fu H; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, 46285, USA. .
Cao D; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, 46285, USA.
Boye KS; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, 46285, USA.
Curtis B; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, 46285, USA.
Schuster DL; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, 46285, USA.
Kendall DM; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, 46285, USA.
Ascher-Svanum H; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, 46285, USA.
Pokaż więcej
Źródło :
Diabetes therapy : research, treatment and education of diabetes and related disorders [Diabetes Ther] 2015 Sep; Vol. 6 (3), pp. 317-28. Date of Electronic Publication: 2015 Jul 05.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Erratum to: Associations Between Glycemic Control, Depressed Mood, Clinical Depression, and Diabetes Distress Before and After Insulin Initiation: An Exploratory, Post Hoc Analysis.
Autorzy :
Ascher-Svanum H; Eli Lilly and Company, Indianapolis, IN, USA. .
Zagar A; Eli Lilly and Company, Indianapolis, IN, USA.
Jiang D; Eli Lilly and Company, Indianapolis, IN, USA.
Schuster D; Eli Lilly and Company, Indianapolis, IN, USA.
Schmitt H; Eli Lilly Benelux, Brussels, Belgium.
Dennehy EB; Eli Lilly and Company, Indianapolis, IN, USA.; Department of Psychological Sciences, Purdue University, West Lafayette, IN, USA.
Kendall DM; Eli Lilly and Company, Indianapolis, IN, USA.
Raskin J; Eli Lilly Canada, Toronto, ON, Canada.
Heine RJ; Eli Lilly and Company, Indianapolis, IN, USA.
Pokaż więcej
Źródło :
Diabetes therapy : research, treatment and education of diabetes and related disorders [Diabetes Ther] 2015 Sep; Vol. 6 (3), pp. 403.
Typ publikacji :
Journal Article; Published Erratum
Czasopismo naukowe
Tytuł :
Is the current standard of care leading to cost-effective outcomes for patients with type 2 diabetes requiring insulin? A long-term health economic analysis for the UK.
Autorzy :
Valentine WJ; Ossian Health Economics and Communications, Basel, Switzerland. Electronic address: .
Curtis BH; Eli Lilly and Company, Indianapolis, IN, USA.
Pollock RF; Ossian Health Economics and Communications, Basel, Switzerland.
Van Brunt K; Lilly Research Center, Windlesham, Surrey, UK.
Paczkowski R; Eli Lilly and Company, Indianapolis, IN, USA.
Brändle M; Division of Endocrinology and Diabetes, Kantonsspital St. Gallen, St. Gallen, Switzerland.
Boye KS; Eli Lilly and Company, Indianapolis, IN, USA.
Kendall DM; Eli Lilly and Company, Indianapolis, IN, USA.
Pokaż więcej
Źródło :
Diabetes research and clinical practice [Diabetes Res Clin Pract] 2015 Jul; Vol. 109 (1), pp. 95-103. Date of Electronic Publication: 2015 Apr 21.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Diabetes Mellitus, Type 2/*drug therapy
Diabetes Mellitus, Type 2/*economics
Hypoglycemic Agents/*administration & dosage
Hypoglycemic Agents/*economics
Insulin/*administration & dosage
Insulin/*economics
Standard of Care/*economics
Aged ; Body Mass Index ; Cost-Benefit Analysis ; Costs and Cost Analysis ; Diabetes Mellitus, Type 2/epidemiology ; Female ; Humans ; Life Expectancy ; Male ; Middle Aged ; Quality of Life ; Retrospective Studies ; United Kingdom/epidemiology
Czasopismo naukowe
Tytuł :
Comment on Zhang et Al. Second-line agents for glycemic control for type 2 diabetes: are newer agents better? Diabetes Care 2014;37:1338-1345.
Autorzy :
Bae J; Eli Lilly and Company, Indianapolis, IN.
Curtis BH; Eli Lilly and Company, Indianapolis, IN .
Kendall DM; Eli Lilly and Company, Indianapolis, IN.
Heine RJ; Eli Lilly and Company, Indianapolis, IN.
Pokaż więcej
Źródło :
Diabetes care [Diabetes Care] 2014 Sep; Vol. 37 (9), pp. e204.
Typ publikacji :
Letter; Comment
MeSH Terms :
Diabetes Mellitus, Type 2/*prevention & control
Hypoglycemic Agents/*therapeutic use
Female ; Humans ; Male
Opinia redakcyjna
Tytuł :
Frederick C. Goetz, MD: a profile of the intersection among science, the fine arts, and education.
Autorzy :
Hoogwerf BJ; Eli Lilly and Co., Indianapolis, IN .
Kendall DM; Eli Lilly and Co., Indianapolis, IN University of Minnesota, Minneapolis, MN.
Seaquist ER; University of Minnesota, Minneapolis, MN.
Pokaż więcej
Źródło :
Diabetes care [Diabetes Care] 2014 Sep; Vol. 37 (9), pp. 2419-23.
Typ publikacji :
Biography; Historical Article; Journal Article
MeSH Terms :
Art*
Education*
Science*
Diabetes Mellitus/*therapy
Kidney Transplantation/*history
Pancreas Transplantation/*history
Health Services ; History, 20th Century ; History, 21st Century ; Humans
Personal Name as Subject :
Goetz FC
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies